NCT01965067View on ClinicalTrials.gov

Influence of Mild Hypothermia on Reversal of Rocuronium With Sugammadex

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

April 30, 2014

Conditions
Underdosing of Other General Anesthetics
Interventions
DRUG

sugammadex

"sugammadex 4.0 mg/kg is administered in deep block state(1 - 2 PTCs) in different temperature state~Reversal effect of sugammadex in temperature state"

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine, Hanyang University Hospital, Seoul

All Listed Sponsors
lead

MSD Korea Ltd.

INDUSTRY

NCT01965067 - Influence of Mild Hypothermia on Reversal of Rocuronium With Sugammadex | Biotech Hunter | Biotech Hunter